(
a,
e) Triple mutants that affect the atypical priming of PfMyoA. speed, ADP-release rate, and actin-activated ATPases for LRA (see also data presented in
Figure 2) compared with the AAA mutant (LRA: R707L/E711R/Y714A; AAA: R707A/E711A/Y714A).(
a) Speed distributions from a representative in vitro motility assay for LRA (1.19 ± 0.18 μm/s, n = 4092) and AAA (1.24 ± 0.24 μm/s, n = 3030). (
b) ADP-release rates from acto-PfMyoA for LRA (117 ± 4 s
−1) and AAA (122 ± 2 s
−1). three experiments, one protein preparation of AAA. (
c) Actin-activated ATPase activity for LRA (Vmax = 46.8 ± 1.0 s
−1; Km = 9.1 ± 0.6 μM) and AAA (Vmax = 42.7 ± 0.9 s
−1; Km = 12.3 ± 0.8 μM). Error, SE of the fit. two experiments, one protein preparation of AAA. (
d) Ensemble force measurements using a utrophin-based loaded in vitro motility assay, showing more data and an expanded x-axis compared with the main
Figure 2f. Temperature, 30°C. (
e) Ensemble force measurement of FL PfMyoA with only MTIP light chain bound. A myosin that produces more force requires higher utrophin concentrations to slow motion. Minus PfELC: 1.57 ± 0.18 nM (red diamonds and solid red line fit); WT, 1.40 ± 0.08 nM; S19A, 2.42 ± 0.17 nM. WT and S19A data are from
Frénal et al., 2017. Error, SE of the fit. Data for minus PfELC are from one protein preparation and two experiments. Skeletal actin was used for all experiments. Temperature, 30°C.